Àü¹ÝÀûÀÎ ½Å°æº´¼º ÅëÁõÀÇ Á¶Àý ¹× Ä¡·á
The General Management and Treatment of Neuropathic Pain
Àü¾çÇö,
¼Ò¼Ó »ó¼¼Á¤º¸
Àü¾çÇö ( Chun Yang-Hyun ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°³»°úÇб³½Ç
KMID : 0362720110490060327
Abstract
Clinically, treatment goal of neuropathic pain focused on not elimination of etiology but management and control of symptoms because we don¡¯t know certain about clear etiology of neuropathic pain yet. The drugs used for the management of neuropathic pain were classified as drugs with strong evidence for benefit(antidepressants, anticonvulsants, opioid analgesics etc.), modest evidence for benefit(mexiletine, carbamazepine, clonidine etc.), preliminary evidence for benefit(NSAIDs, dextromethorphan, topiramate etc.). Finally, the treatment for trigeminal neuralgia was outlined separately since this disorder responds to a different group of drugs than other neuropathic pain conditions.
Å°¿öµå
neuropathic pain; trigeminal neuralgia; antidepressants; anticonvulsants; carbamazepine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸